Mitchell & Pahl Private Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.6M Buy
7,175
+280
+4% +$95.8K 0.95% 40
2026
Q1
$2.43M Buy
6,895
+204
+3% +$72.7K 0.99% 43
2025
Q4
$2.19M Buy
6,691
+36
+0.5% +$11.4K 0.91% 44
2025
Q3
$1.88M Buy
6,655
+42
+0.6% +$12.2K 0.79% 50
2025
Q2
$1.85M Buy
6,613
+296
+5% +$83.9K 0.82% 46
2025
Q1
$1.97M Buy
6,317
+438
+7% +$129K 0.92% 43
2024
Q4
$1.53M Buy
5,879
+676
+13% +$201K 0.72% 56
2024
Q3
$1.68M Buy
5,203
+96
+2% +$31.4K 0.78% 47
2024
Q2
$1.6M Buy
5,107
+13
+0.3% +$3.82K 0.84% 46
2024
Q1
$1.45M Buy
5,094
+260
+5% +$76.1K 0.76% 50
2023
Q4
$1.39M Sell
4,834
-181
-4% -$49.3K 0.79% 46
2023
Q3
$1.35M Buy
5,015
+509
+11% +$127K 0.8% 44
2023
Q2
$1M Buy
4,506
+343
+8% +$79.6K 0.6% 55
2023
Q1
$1.01M Buy
4,163
+288
+7% +$70.7K 0.63% 57
2022
Q4
$1.02M Buy
3,875
+245
+7% +$65.7K 0.67% 53
2022
Q3
$818K Buy
3,630
+351
+11% +$85.1K 0.6% 58
2022
Q2
$798K Buy
3,279
+317
+11% +$77.7K 0.55% 66
2022
Q1
$716K Buy
2,962
+466
+19% +$107K 0.46% 79
2021
Q4
$562K Buy
2,496
+169
+7% +$35.7K 0.36% 91
2021
Q3
$495K Buy
2,327
+256
+12% +$58.9K 0.36% 89
2021
Q2
$505K Buy
2,071
+372
+22% +$91.5K 0.36% 90
2021
Q1
$423K Buy
1,699
+212
+14% +$50.6K 0.33% 95
2020
Q4
$342K Buy
+1,487
New +$343K 0.29% 106

Other funds holding AMGN

Mitchell & Pahl Private Wealth's AMGN Position: Q2 2026 in Review

Mitchell & Pahl Private Wealth increased its Amgen (AMGN) stake by 4.1% in Q2 2026, buying an estimated $95.8K and bringing the position to 7,175 shares worth $2.6M. The position accounts for 0.95% of the portfolio, ranked #40.

Mitchell & Pahl Private Wealth first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Mitchell & Pahl Private Wealth held 7,175 shares of Amgen worth $2.6M as of Q2 2026.
  • Mitchell & Pahl Private Wealth bought 280 Amgen shares in Q2 2026, an estimated $95.8K.
  • Amgen made up 0.95% of Mitchell & Pahl Private Wealth's portfolio in Q2 2026, its #40 holding.
  • Mitchell & Pahl Private Wealth first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
  • 659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Mitchell & Pahl Private Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.